Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Generex Biotechnology Corp (Nasdaq: GNBT) shares rose 25% in early market trading before falling on news the company will acquire a 51% stake in Global Medical Direct.

So what: There was confusion in the market this morning causing a wild swing in Generex's share price and halting trading for a period. Investors are also trying to digest news of the Global Medical purchase and a reverse stock split and rights offering by the company.

Now what: This was a confusing morning for investors trying to make sense of a lot of news. The Global Medical Direct stake will be 51% of the company, expecting $30 million in revenue and $8 million in net income. For the stock offering, as of now it appears the company will offer common stock and warrants to existing shareholders if a reverse stock split is approved on Friday.

Interested in more info on Generex Biotechnology? Add it to your watchlist here by clicking here.

Fool contributor Travis Hoium does not have a position in any company mentioned. Try any of our Foolish newsletter services free for 30 days

True to its name, The Motley Fool is made up of a motley assortment of writers and analysts, each with a unique perspective; sometimes we agree, sometimes we disagree, but we all believe in the power of learning from each other through our Foolish community. The Motley Fool has a disclosure policy.